Category: Clinical Trials

Patient value: Perspectives from the advocacy community

The paradigm of decision making for healthcare must change. It is imperative that patients are part of the equation. According to this article, co-authored by Bonnie J. Addario, “There is substantial evidence to show that patient-centred care improves patient satisfaction, adherence to medications, improved chronic disease control, quality of care and health outcomes while reducing… Read More

Posted by ALCF Staff on September 20th, 2017

Patient Engagement is Mandatory

Bonnie and Daryl Pritchard, PhD, from the Personalized Medicine Coalition talk about the importance of personalized medicine and how a registry that can serve as a repository for data on patients with lung cancer— is a means to empower patients and assist care providers to deliver personalized medicine in a patient-centered manner. Read the full… Read More

Posted by ALCF Staff on August 9th, 2017

Lung Cancer Updates from 2017 ASCO Annual Meeting

Each year in early June the American Society for Clinical Oncology holds its Annual Meeting (called simply “ASCO”) in Chicago. The theme for the 2017 meeting was “Making a Difference in Cancer Care WITH YOU.” Over 39,000 cancer researchers, clinicians, patient advocates, and industry representatives from around the world gathered to discuss the latest scientific… Read More

Posted by Janet Freeman-Daily on July 26th, 2017

ALCF Announces Winners of a Crowdsourcing Challenge to Increase Patient Enrollment in Oncology Clinical Trials

Two winners will be awarded a total of $180,000 for the Bonnie J. Addario Lung Cancer Foundation (ALCF) Clinical Trial Innovation Prize, an international crowdsourcing challenge seeking innovative ways to increase cancer patient enrollment in clinical trials. First prize was awarded to Samir Housri and Nadine Housri who developed theMednet, a social network for physicians,… Read More

Posted by ALCF Staff on May 15th, 2017

ALCMI and Biocept Announce a Landmark Liquid Biopsy Clinical Trial

The Addario Lung Cancer Medical Institute (ALCMI) and Biocept, Inc., a leading commercial provider of clinically actionable liquid biopsy tests designed to improve the outcomes of cancer patients, announce a clinical collaboration and initiation of the landmark ALCMI-009 liquid biopsy clinical trial, which was developed and will be conducted by ALCMI and its consortium of… Read More

Posted by ALCF Staff on May 10th, 2017

New Clinical Trial for Non-squamous Non-small Cell Lung Cancer

A new study led by researchers at the Indiana University Melvin and Bren Simon Cancer Center may help answer questions about the role of immunotherapy in combination with chemotherapy in treating lung cancer patients whose disease worsened after initial response to immunotherapy. The randomized phase II study, known as HCRN LUN15-233, involves Taxotere® with or… Read More

Posted by ALCF Staff on March 28th, 2017

Do you know a ROS1-fusion positive cancer patient?

In May, 2016, the Bonnie J. Addario Lung Cancer Foundation launched the Global ROS1 Initiative, in partnership with cancer patients whose tumors are driven by ROS1 gene fusions. These ROS1 gene fusions are abnormal changes in cells that drive the growth and spread of several different cancer types such as non-small cell lung, gastric, ovarian,… Read More

Posted by Dr. Guneet Walia on February 23rd, 2017

New Search Tool to Find Clinical Trials

New lung cancer treatments such as immunotherapy and targeted treatments are being researched in clinical trials every day, and we encourage you to get involved. That’s why we’re proud to announce a new partnership with digital health startup Antidote that will make it easier than ever for you to connect with medical research. Using our… Read More

Posted by ALCF Staff on January 18th, 2017

New Lung Cancer Registry Launched Today

The Bonnie J. Addario Lung Cancer Foundation (ALCF), the American Lung Association (ALA) and AltaVoice (formerly known as PatientCrossroads) today announced the new Lung Cancer Registry. The Registry is a place to gather and store detailed information for patients with lung cancer, which kills more Americans each year than the next three most frequent types… Read More

Posted by ALCF Staff on November 4th, 2016

Study: An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies

This is a Phase 1/2 clinical research study for subjects with advanced malignancies. This study will be conducted in three treatment groups with each treatment having two parts; a dose escalation (Part 1) and an expansion (Part 2). This study is accepting patients with Diffuse Large B-Cell Lymphoma (DLBCL), Acute Myeloid Leukemia, Myelodysplastic /Myeloproliferative neoplasms… Read More

Posted by ALCF Staff on October 18th, 2016